Pancreatic Cancer Research

ResearcherShandong Tumor HospitalActive in the last 2 years

Jinbo Yue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5768-8622; OpenAlex author ID A5010796711. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Study protocol for a single-arm phase Ib/II trial of Ivonescimab combined with adapted guided stereotactic body radiotherapy and chemotherapy in patients with … Last author DOI 10.1186/s12885-025-14944-w↗
  2. [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00259-023-06271-8↗
  3. Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally adv… Co-author DOI 10.1002/pro6.1156↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ziniu Tang · 1 shared paper, 2025 · strength 0.27
  2. Hongxin Niu · 1 shared paper, 2022 · strength 0.19
  3. Yanfen Zheng · 1 shared paper, 2022 · strength 0.19
  4. Xiang Zhang · 1 shared paper, 2023 · strength 0.18
  5. Ziyuan Zhu · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.